News from the world
21
Mar
EU pharmaceutical policy: MEPs support comprehensive reform
MEPs adopted their proposals to revamp EU pharmaceutical legislation, to foster innovation and enhance...
20
Riforma farmaceutica: il Parlamento Ue non tocca (quasi) i tempi della tutela regolatoria
Nuovo codice del farmaco europeo: il Parlamento Ue potrebbe accettare di estendere a 7,5 anni la tutela...
15
US FDA Final Guidance: Controlled Correspondence Related to Generic Drug Development
FDA is committed to ensuring current and prospective abbreviated new drug application (ANDA) applicants...
FDA publishes artificial intelligence paper
FDA published its new paper, “Artificial Intelligence and Medical Products: How CBER, CDER, CDRH,...
latest news
12 Jan
Generic drug trade group warns wastewater plan ‘massively underestimates’ costs
US CDER Office of Compliance Annual Report, Fiscal Year 2023
11 Jan
US FDA Revised Draft Guidance: Requests for Reconsideration at the Division Level Under GDUFA
India introduces new GMP standards for drugmakers
10 Jan
AIFA: la nuova organizzazione è attesa entro fine gennaio
Biotecnologie: Ministero Affari Esteri avvia un tavolo di lavoro per l’internazionalizzazione del settore
Riforma legislazione UE: gli impatti sul settore farmaceutico secondo il PGEU
09 Jan
FDA Launches New Webpage for Searching Pharmaceutical Quality Documents
<<<5 6 7>>>